Want to see AU:PTX full AI Analyst Report?

Prescient Therapeutics Limited (PTX) Cash flow

24 Followers

Prescient Therapeutics Limited Cash Flow

AU:PTX's free cash flow for Q4 2026 was AU$-680.95K. For the 2026 fiscal year, AU:PTX's free cash flow was decreased by AU$19.29K and operating cash flow was AU$-680.95K. See a summary of the company’s cash flow.

Cash Flow	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Operating Cash Flow	AU$ -7.22M	AU$ -7.24M	AU$ -7.40M	AU$ -6.19M	AU$ -4.31M
Investing Cash Flow	AU$ 0.00	AU$ 4.00M	AU$ 12.00M	AU$ -16.00M	AU$ -4.43K
Financing Cash Flow	AU$ 9.34M	AU$ -330.49K	AU$ 18.15K	AU$ 15.83M	AU$ 428.29K
End Cash Position	AU$ 9.03M	AU$ 6.91M	AU$ 10.49M	AU$ 5.90M	AU$ 12.26M
Free Cash Flow	AU$ -7.22M	AU$ -7.24M	AU$ -7.40M	AU$ -6.19M	AU$ -4.32M

Currency in AUD